Centre Hospitalier Universitaire de Nice: Multiple Sclerosis trials
The registry lists 14 Multiple Sclerosis studies with Centre Hospitalier Universitaire de Nice as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 3 3No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Use of a Portable Pupillometer to Detect Optic Nerve Impairment in Patients With Suspected Multiple SclerosisNot yet recruitingNCT07837050Not applicable
- Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological ExaminationRecruitingNCT07135752Not applicable
- Diagnostic Value of eVOGRecruitingNCT05776511Not applicable
- RIS International CohortRecruitingNCT05388331
- Epstein Barr Virus Infection in Patients With Radiologically Isolated SyndromeCompletedNCT05815108
- Silent Progression Activity Monitoring - SPAM StudyCompletedNCT05650281
- COVID-19 on Disease Activity in Radiologically Isolated Syndrome CohortCompletedNCT05387395
- LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMABActive, not recruitingNCT05210621Phase 3
- Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory DiseasesCompletedNCT05088473
- Validation of the French Adaptation of the MSWDQ-23 QuestionnaireCompletedNCT04860791
- Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.Active, not recruitingNCT04595799
- Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated SyndromeCompletedNCT03122652Phase 3
- A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension PeriodCompletedNCT02587195Phase 3
- Rehabilitation Protocol for Disorders on Hand Sensitivity in Multiple Sclerosis Patients.TerminatedNCT01866878Not applicable